With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the "Retrievable Era" using TAVR products

SUZHOU, China, June 26, 2021 /PRNewswire/ -- The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusElite®") developed by Peijia Medical (9996. HK) is approved for marketing by the National Medical Products Administration (NMPA) in June 2021 (Reg....

from PR Newswire: https://ift.tt/3gTlYn4